Bottom line
How much do GDOC and BHCHX overlap?
51% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 58.4% of GDOC's assets and 51.0% of BHCHX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings GDOC and BHCHX have in common
| Holding | % of GDOC | % of BHCHX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 13.28% | 13.66% | 13.28% |
| Johnson & Johnson JNJ | 8.07% | 5.56% | 5.56% |
| Merck & Company Inc MRK | 5.94% | 2.48% | 2.48% |
| Guardant Health Inc GH | 5.34% | 2.17% | 2.17% |
| Astrazeneca Plc AZN | 4.84% | 2.49% | 2.49% |
| Thermo Fisher Scientific Inc TMO | 4.52% | 3.91% | 3.91% |
| Argenx Se ARGX | 4.07% | 4.23% | 4.07% |
| Intuitive Surgical Inc ISRG | 3.90% | 1.74% | 1.74% |
| Edwards Lifesciences Corp EW | 2.98% | 2.64% | 2.64% |
| Roivant Sciences Ltd ROIV | 2.39% | 3.88% | 2.39% |
| Mettler-toledo International Inc MTD | 1.59% | 5.60% | 1.59% |
| Vertex Pharmaceuticals Inc VRTX | 1.48% | 2.61% | 1.48% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GDOC
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
- Lonza Group Ag — 2.80%
- Dexcom Inc — 2.79%
- Agilent Technologies Inc — 2.77%
- Cencora Inc — 2.34%
- Apogee Therapeutics Inc — 1.97%
- Royalty Pharma Plc — 1.77%
- Penumbra Inc — 1.61%
- Goldman Sachs Trust — 1.43%
- Cytokinetics Inc — 1.40%
- Ionis Pharmaceuticals Inc — 1.37%
- Xenon Pharmaceuticals Inc — 1.35%
Only in BHCHX
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
- Billiontoone Inc — 2.84%
- Madrigal Pharmaceuticals Inc — 2.12%
- Revolution Medicines Inc — 2.05%
- Elanco Animal Health Inc — 2.05%
- Kymera Therapeutics Inc — 2.01%
- Gilead Sciences Inc — 1.99%
- Natera Inc — 1.93%
- Protagonist Therapeutics Inc — 1.72%
- Elevance Health Inc — 1.69%
Asset mix
| Asset type | GDOC | BHCHX |
|---|---|---|
| Stocks | 98.5% | 97.7% |
| Cash & short-term funds | 1.4% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | GDOC | BHCHX |
|---|---|---|
| US | 76.3% | 79.7% |
| GB | 6.6% | 2.5% |
| NL | 4.1% | 4.5% |
| CH | 3.9% | — |
| BM | 2.4% | 3.9% |
| IL | — | 3.9% |
| JP | 3.5% | — |
| CA | 1.9% | 1.9% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do GDOC and BHCHX overlap?
What stocks do GDOC and BHCHX have in common?
Should I own both GDOC and BHCHX?
Which holds more stocks, GDOC or BHCHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.